
Sign up to save your podcasts
Or
Ella Al-Shamahi meets two women on the frontline in the fight against malaria.
Dr Ify Aniebo is from Nigeria, the country worst hit by malaria. She is an Associate professor with the African Centre of Excellence for Genomics of Infectious Diseases, where she works to improve the country's response to drug resistance and malarial transmission.
Dr Mehreen Datoo is a clinical lecturer in Infectious Diseases at the University of Oxford and she’s on the team that developed the R21/Matrix-M, the WHO approved vaccine that will be rolled out across Africa in 2024.
Produced by Alice Gioia, Emily Naylor and Jane Thurlow.
(Image: (L) Dr Mehreen Datoo, courtesy of Dr Mehreen Datoo. (R) Dr Ify Aniebo, courtesy Dr Ify Aniebo.)
4.5
6969 ratings
Ella Al-Shamahi meets two women on the frontline in the fight against malaria.
Dr Ify Aniebo is from Nigeria, the country worst hit by malaria. She is an Associate professor with the African Centre of Excellence for Genomics of Infectious Diseases, where she works to improve the country's response to drug resistance and malarial transmission.
Dr Mehreen Datoo is a clinical lecturer in Infectious Diseases at the University of Oxford and she’s on the team that developed the R21/Matrix-M, the WHO approved vaccine that will be rolled out across Africa in 2024.
Produced by Alice Gioia, Emily Naylor and Jane Thurlow.
(Image: (L) Dr Mehreen Datoo, courtesy of Dr Mehreen Datoo. (R) Dr Ify Aniebo, courtesy Dr Ify Aniebo.)
5,447 Listeners
1,806 Listeners
7,656 Listeners
527 Listeners
1,744 Listeners
1,105 Listeners
2,081 Listeners
1,055 Listeners
381 Listeners
524 Listeners
304 Listeners
255 Listeners
723 Listeners
3,046 Listeners
29 Listeners
63 Listeners
96 Listeners
266 Listeners
21 Listeners
13 Listeners
16 Listeners
44 Listeners
114 Listeners